Cargando…
Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach
Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diag...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572018/ https://www.ncbi.nlm.nih.gov/pubmed/23418544 http://dx.doi.org/10.1371/journal.pone.0056246 |
_version_ | 1782259256191352832 |
---|---|
author | Biswas, Sagarika Sharma, Saurabh Saroha, Ashish Bhakuni, D. S. Malhotra, Rajesh Zahur, Muzna Oellerich, Michael Das, Hasi R. Asif, Abdul R. |
author_facet | Biswas, Sagarika Sharma, Saurabh Saroha, Ashish Bhakuni, D. S. Malhotra, Rajesh Zahur, Muzna Oellerich, Michael Das, Hasi R. Asif, Abdul R. |
author_sort | Biswas, Sagarika |
collection | PubMed |
description | Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and α1B-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease. |
format | Online Article Text |
id | pubmed-3572018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35720182013-02-15 Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach Biswas, Sagarika Sharma, Saurabh Saroha, Ashish Bhakuni, D. S. Malhotra, Rajesh Zahur, Muzna Oellerich, Michael Das, Hasi R. Asif, Abdul R. PLoS One Research Article Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and α1B-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease. Public Library of Science 2013-02-13 /pmc/articles/PMC3572018/ /pubmed/23418544 http://dx.doi.org/10.1371/journal.pone.0056246 Text en © 2013 Biswas et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Biswas, Sagarika Sharma, Saurabh Saroha, Ashish Bhakuni, D. S. Malhotra, Rajesh Zahur, Muzna Oellerich, Michael Das, Hasi R. Asif, Abdul R. Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach |
title | Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach |
title_full | Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach |
title_fullStr | Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach |
title_full_unstemmed | Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach |
title_short | Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach |
title_sort | identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572018/ https://www.ncbi.nlm.nih.gov/pubmed/23418544 http://dx.doi.org/10.1371/journal.pone.0056246 |
work_keys_str_mv | AT biswassagarika identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT sharmasaurabh identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT sarohaashish identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT bhakunids identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT malhotrarajesh identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT zahurmuzna identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT oellerichmichael identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT dashasir identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach AT asifabdulr identificationofnovelautoantigeninthesynovialfluidofrheumatoidarthritispatientsusinganimmunoproteomicsapproach |